China SXT Pharmaceuticals, Inc.
SXTC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 9.9% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25.5% | 25.5% | 16.2% | 16.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -222.6% | -222.6% | -68.7% | -68.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -274.4% | -274.4% | -96.8% | -96.8% |
| EPS Diluted | -0.51 | -0.51 | -0.99 | -0.99 |
| % Growth | 0% | 48.5% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |